Klariv Advanced
Research Institute.
Born in Palo Alto, our institute is led by a team of scientists from Stanford and MIT, dedicated to reversing the myopia epidemic through cutting-edge optical and pharmacological breakthroughs.
Combining decades of ophthalmic research into a unified brand.
Average reduction in myopia progression in our multi-center clinical trials.
Leveraging the Boao Lecheng International Medical Tourism Pilot Zone for early access.
Ivy League Heritage
Our multidisciplinary team combines clinical excellence with silicon-valley speed, featuring expertise from the world's most prestigious vision research centers.
Dr. Marcus Weber
Expert in non-invasive myopic defocus. Leading our longitudinal clinical studies.
Sarah Chen, MBA
Driving the mission to bridge world-class optical tech with pediatric healthcare.
Dr. James Li
Specialist in semiconductor-based red light therapy and AI-driven monitoring.
Bringing US Innovation
to the Children of China.
Recognizing China as the epicenter of the myopia crisis, Klariv is fast-tracking the deployment of our advanced medical suite to Tier-1 cities and the Boao Lecheng International Medical Zone.
- Pilot trials in collaboration with top Chinese Ophthalmic Centers.
- Localization of AI monitoring for parent-teacher coordination.
- Strategic partnership for safe pharmacological distribution.
